Share-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule Of Board of Director Awards And Annual Executive RSU Grants

Versigent has granted RSUs to non-employee members of the Board of Directors as detailed in the table below:

Grant Date

RSUs granted

Grant Date Fair Value (1)

Vesting Date

Shares Issued Upon Vesting

Fair Value of Shares at Issuance

Shares Withheld to Cover Withholding Taxes

(dollars in millions)

April 2026

31,008

2027 (2)

N/A

(1)Determined based on the closing price of the Company’s ordinary shares on the date of the grant.

(2)Pursuant to their respective award agreements the RSUs vest on the day immediately preceding the next Annual General Meeting of Shareholders occurring after their grant.

The details of the annual executive grants are as follows:

Grant Date

RSUs Granted

Grant Date Fair Value

Time-Based Award Vesting Dates

Performance-Based Award Vesting Date

(in millions)

April 2026

1.08

Annually in February, 2027 - 2029

December 31, 2028

A summary of RSU activity, including award grants, vesting and forfeitures is provided below:


	RSUs	Weighted Average Grant Date Fair Value
	(in thousands)
Nonvested, January 1, 2026	292	$	79.10
Granted	1,112	$	36.41
Vested	(135)	$	60.12
Forfeited	(33)	$	64.98
Conversion and employee transfers (1)	1,096
Nonvested, June 30, 2026 (2)	2,332	$	33.36

(1)Reflects the conversion of outstanding equity awards to executives under the Former Parent Plan into Versigent equity awards in conjunction with the Spin-Off, along with the transfer of certain corporate employees to Versigent.

(2)Nonvested RSUs and the corresponding weighted average grant date fair value as of June 30, 2026 are presented on a Versigent basis using the conversion factor described above in connection with the Spin-Off.

Schedule of Share-based Compensation Restricted Stock Units Performance Awards Weighting

Each executive will receive between 0% and 240% (200% prior to 2025) of his or her target performance-based award based on the Company’s performance against established company-wide performance metrics, which are:

Metric

2026
Grant

2025 Former Parent Grant

2024 Former Parent Grant

Average return on invested capital (1)

80%

70%

N/A

Adjacent market revenue

20%

30%

N/A

Relative total shareholder return (2)

(3)

33%

Average return on net assets (4)

N/A

33%

Cumulative net income

N/A

33%

(1)Average return on invested capital is measured by tax-affected operating income divided by average invested capital. Average invested capital is measured by the sum of average total shareholders’ equity plus average net debt for each calendar year during the respective performance period.

(2)Relative total shareholder return is measured by comparing the average closing price per share of the Company’s ordinary shares for the specified trading days in December of the performance period to the average closing price per share of the Company’s ordinary shares for the specified trading days in December of the year preceding the grant, including dividends, and assessed against a comparable measure of competitor and peer group companies.

(3)The performance-based RSUs granted in 2025 and 2026 are subject to a performance modifier based on relative total shareholder return, whereby the ultimate payout level of the performance-based RSUs may be adjusted upwards by 20% if relative total shareholder return is in the upper quartile against a comparable measure of competitor and peer group companies or downwards by 20% if in the bottom quartile for the specified trading days of the performance period as defined above. There will be no adjustment if relative total shareholder return is in the middle quartiles.

(4)Average return on net assets is measured by tax-affected operating income divided by average net working capital plus average net property, plant and equipment for each calendar year during the respective performance period.